Fuanna(002327)2020-10-22 16:00Financial Performance - Net profit attributable to shareholders was CNY 107,365,328.08, representing an increase of 11.78% year-on-year[11]. - Operating revenue for the period was CNY 598,551,072.52, reflecting a year-on-year growth of 1.29%[11]. - Basic earnings per share were CNY 0.13, up 13.79% compared to the same period last year[11]. - The company's operating income for the current period is approximately ¥123.89 million, compared to ¥102.50 million in the previous period, reflecting an increase of about 21%[67]. - The net profit for the current period is approximately ¥107.37 million, up from ¥90.97 million in the previous period, representing a growth of around 18%[67]. - The total revenue for the current period is approximately ¥583.14 million, compared to ¥505.21 million in the previous period, indicating an increase of about 15%[72]. - The total profit for the current period was CNY 325,365,886.59, compared to CNY 292,561,429.46 in the previous period, marking an increase of 11.24%[87]. - The company's operating profit was CNY 315,537,814.28, an increase from CNY 290,793,612.42 in the previous period, reflecting a growth of 8.51%[87]. Cash Flow and Liquidity - The net cash flow from operating activities was CNY 51,642,597.37, a significant decrease of 85.11% year-on-year[11]. - Cash and cash equivalents decreased by 67.49% compared to the beginning of the period, primarily due to dividend distribution and the maturity of bank acceptance bills[24]. - Net cash flow from operating activities decreased by 85.11% compared to the previous period, mainly due to increased bank acceptance bill payments to suppliers and reduced collections from distributors[28]. - Net cash flow from investing activities decreased by 166.31% compared to the previous period, primarily due to increased cash payments for investments[28]. - Total cash and cash equivalents at the end of the period decreased to ¥189,456,275.06 from ¥441,892,781.42[100]. - The company reported a net decrease in cash and cash equivalents of ¥360,174,537.61, compared to a decrease of ¥46,240,310.57 in the prior period[100]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,221,592,229.66, a decrease of 10.23% compared to the end of the previous year[11]. - Total liabilities decreased to CNY 757,795,748.82 from CNY 1,138,236,072.30, a reduction of about 33.4%[51]. - The company's total assets as of September 30, 2020, were CNY 3,978,731,879.37, down from CNY 4,254,623,404.83 at the end of 2019, a decrease of about 6.5%[58]. - The company reported total liabilities of CNY 1,138,236,072.30, with current liabilities at CNY 1,108,202,638.77 and non-current liabilities at CNY 30,033,433.53[116]. - The total current assets decreased from CNY 2,105,142,583.68 to CNY 2,635,913,112.98, showing a positive trend in asset management[120]. Shareholder Information - The total number of shareholders at the end of the reporting period was 28,624[15]. - The largest shareholder, Lin Guofang, holds 37.14% of the shares, totaling 313,111,710 shares[15]. - The company's equity attributable to shareholders decreased to CNY 3,463,796,480.84 from CNY 3,564,192,368.40, a decline of approximately 2.8%[54]. Research and Development - Research and development expenses for Q3 2020 amounted to CNY 24,809,944.28, compared to CNY 19,348,365.42 in Q3 2019, reflecting a rise of approximately 28.5%[65]. - Research and development expenses for the current period were CNY 47,790,980.90, slightly down from CNY 49,488,806.60 in the previous period[91]. Future Outlook - The company does not anticipate any significant changes in its operational strategy or market expansion plans in the near term[20]. - Future outlook includes plans for market expansion and potential new product launches, although detailed projections were not provided in the report[64].